This work is licensed under the Creative Commons Attribution-NonCommercial-NoDerivatives 4.0 International License.
Bertram, M. Y., Lauer, J. A., De Joncheere, K., Edejer, T., Hutubessy, R., Kieny, M.-P., & Hill, S. R. (2016). Cost–effectiveness thresholds: Pros and cons. Bulletin of the World Health Organization, 94(12), 925–930. https://doi.org/10.2471/blt.15.164418BertramM. Y.LauerJ. A.De JoncheereK.EdejerT.HutubessyR.KienyM.-P.HillS. R.2016Cost–effectiveness thresholds: Pros and cons9412925930https://doi.org/10.2471/blt.15.16441810.2471/BLT.15.164418Search in Google Scholar
Carson, R. (2012). Contingent valuation: A comprehensive bibliography and history. Edward Elgar Publishing.CarsonR.2012Edward Elgar PublishingSearch in Google Scholar
Culyer, A. J. (2016). Cost-effectiveness thresholds in health care: A bookshelf guide to their meaning and use. Health Economics, Policy and Law, 11(4), 415–432. https://doi.org/10.1017/s1744133116000049CulyerA. J.2016Cost-effectiveness thresholds in health care: A bookshelf guide to their meaning and use114415432https://doi.org/10.1017/s174413311600004910.1017/S1744133116000049Search in Google Scholar
Desaigues, B., Ami, D., Bartczak, A., Braun-Kohlová, M., Chilton, S., Czajkowski, M., et al. (2011). Economic valuation of air pollution mortality: A 9-country contingent valuation survey of value of a life year (VOLY). Ecological Indicators, 11(3), 902–910. https://doi.org/10.1016/j.ecolind.2010.12.006DesaiguesB.AmiD.BartczakA.Braun-KohlováM.ChiltonS.CzajkowskiM.2011Economic valuation of air pollution mortality: A 9-country contingent valuation survey of value of a life year (VOLY)113902910https://doi.org/10.1016/j.ecolind.2010.12.00610.1016/j.ecolind.2010.12.006Search in Google Scholar
Drummond, M. F., Sculpher, M. J., Claxton, K., Stoddart, G. L., & Torrance, G. W. (2015). Methods for the economic evaluation of health care programmes. Oxford university press.DrummondM. F.SculpherM. J.ClaxtonK.StoddartG. L.TorranceG. W.2015Oxford university pressSearch in Google Scholar
Friedman, H. S. (2021). Ultimate price: The value we place on life. University of California Press.FriedmanH. S.2021University of California PressSearch in Google Scholar
Gallacher, K., Morrison, D., Jani, B., Macdonald, S., May, C. R., Montori, V. M., et al. (2013). Uncovering treatment burden as a key concept for stroke care: A systematic review of qualitative research. PLoS Med, 10(6), e1001473 https://doi.org/10.1371/journal.pmed.1001473.GallacherK.MorrisonD.JaniB.MacdonaldS.MayC. R.MontoriV. M.2013Uncovering treatment burden as a key concept for stroke care: A systematic review of qualitative research106e1001473https://doi.org/10.1371/journal.pmed.1001473.10.1371/journal.pmed.1001473Search in Google Scholar
Giergiczny, M. (2006). Wycena wartości statystycznego życia ludzkiego przy wykorzystaniu metody wyborów z eksperymentami. Ekonomia i Środowisko, 2, 42–56.GiergicznyM.2006Wycena wartości statystycznego życia ludzkiego przy wykorzystaniu metody wyborów z eksperymentami24256Search in Google Scholar
Hanemann, W. M. (1984). Welfare evaluation in contingent valuation experiments with discrete responses. American Journal of Agricultural Economics, 66(3), 332–341. https://doi.org/10.2307/1240800HanemannW. M.1984Welfare evaluation in contingent valuation experiments with discrete responses663332341https://doi.org/10.2307/124080010.2307/1240800Search in Google Scholar
Hutubessy, R., Chisholm, D., & Edejer, T. T. T. (2003). Generalized cost-effectiveness analysis for national-level priority-setting in the health sector. Cost Effectiveness and Resource Allocation, 1(1), 1–13.HutubessyR.ChisholmD.EdejerT. T. T.2003Generalized cost-effectiveness analysis for national-level priority-setting in the health sector1111310.1186/1478-7547-1-1Search in Google Scholar
Jakubiak-Lasocka, J., & Jakubczyk, M. (2014). Cost-effectiveness versus cost-utility analyses: What are the motives behind using each and how do their results differ?—A Polish example. Value in Health Regional Issues, 4, 66–74. https://doi.org/10.1016/j.vhri.2014.06.008Jakubiak-LasockaJ.JakubczykM.2014Cost-effectiveness versus cost-utility analyses: What are the motives behind using each and how do their results differ?—A Polish example46674https://doi.org/10.1016/j.vhri.2014.06.00810.1016/j.vhri.2014.06.008Search in Google Scholar
Johannesson, M., & Johansson, P. O. (1996). To be, or not to be, that is the question: An empirical study of the WTP for an increased life expectancy at an advanced age. Journal of Risk and Uncertainty, 13(2), 163–174. https://doi.org/10.1007/bf00057866JohannessonM.JohanssonP. O.1996To be, or not to be, that is the question: An empirical study of the WTP for an increased life expectancy at an advanced age132163174https://doi.org/10.1007/bf0005786610.1007/BF00057866Search in Google Scholar
Markiewicz, O. (2008). Analiza opłacalności programów ochrony zdrowia na podstawie wyceny statystycznego życia i wyceny dodatkowego roku przeżycia w Polsce. Praca doktorska przygotowana pod kierunkiem prof. dr hab.Tomasza Żylicza, Uniwersytet Warszawski, Wydział Nauk Ekonomicznych, Warszawa.MarkiewiczO.2008Praca doktorska przygotowana pod kierunkiem prof. dr hab.Tomasza Żylicza,Uniwersytet Warszawski, Wydział Nauk EkonomicznychWarszawaSearch in Google Scholar
McFadden, D. (1974). Conditional logit analysis of qualitative choice behavior. Frontiers in Econometrics, New York Academic Press, 105–142.McFaddenD.1974Conditional logit analysis of qualitative choice behaviorNew York Academic Press105142Search in Google Scholar
McCabe, C., Claxton, K., & Culyer, A. J. (2008). The NICE cost-effectiveness threshold. Pharmacoeconomics, 26(9), 733–744.McCabeC.ClaxtonK.CulyerA. J.2008The NICE cost-effectiveness threshold26973374410.2165/00019053-200826090-00004Search in Google Scholar
Meyerhoff, J., & Liebe, U. (2006). Protest beliefs in contingent valuation: Explaining their motivation. Ecological Economics, 57(4), 583–594. https://doi.org/10.1016/j.ecolecon.2005.04.021MeyerhoffJ.LiebeU.2006Protest beliefs in contingent valuation: Explaining their motivation574583594https://doi.org/10.1016/j.ecolecon.2005.04.02110.1016/j.ecolecon.2005.04.021Search in Google Scholar
O’Mahony, J. F., & Coughlan, D. (2016). The Irish cost-effectiveness threshold: Does it support rational rationing or might it lead to unintended harm to Ireland’s health system?. Pharmacoeconomics, 34(1), 5–11. https://doi.org/10.1007/s40273-015-0336-1O’MahonyJ. F.CoughlanD.2016The Irish cost-effectiveness threshold: Does it support rational rationing or might it lead to unintended harm to Ireland’s health system?341511https://doi.org/10.1007/s40273-015-0336-110.1007/s40273-015-0336-1Search in Google Scholar
Orlewska, E., & Mierzejewski, P. (2000). Polskie wytyczne przeprowadzania badań farmakoekonomicznych (projekt). Farmakoekonomika, 4(supl 1), 2–11.OrlewskaE.MierzejewskiP.2000Polskie wytyczne przeprowadzania badań farmakoekonomicznych (projekt)4supl 1211Search in Google Scholar
Orlewska, E., & Mierzejewski, P. (2003). Project of polish guidelines for conducting pharmacoeconomic evaluations in comparison to international health economic guidelines. The European Journal of Health Economics, formerly: HEPAC, 4(4), 296–303. https://doi.org/10.1007/s10198-003-0185-2OrlewskaE.MierzejewskiP.2003Project of polish guidelines for conducting pharmacoeconomic evaluations in comparison to international health economic guidelines44296303https://doi.org/10.1007/s10198-003-0185-210.1007/s10198-003-0185-2Search in Google Scholar
Schulman, K. A. (1991). Cost Effectiveness of Low-Dose Zidovudine Therapy for Asymptomatic Patients with Human Immunodeficiency Virus (HIV) Infection. Annals of Internal Medicine, 114(9), 798–802. https://doi.org/10.7326/0003-4819-114-9-798SchulmanK. A.1991Cost Effectiveness of Low-Dose Zidovudine Therapy for Asymptomatic Patients with Human Immunodeficiency Virus (HIV) Infection1149798802https://doi.org/10.7326/0003-4819-114-9-79810.7326/0003-4819-114-9-798Search in Google Scholar
Thokala, P., Ochalek, J., Leech, A. A., & Tong, T. (2018). Cost-Effectiveness Thresholds: the Past, the Present and the Future. PharmacoEconomics, 36(5), 509–522. https://doi.org/10.1007/s40273-017-0606-1ThokalaP.OchalekJ.LeechA. A.TongT.2018Cost-Effectiveness Thresholds: the Past, the Present and the Future365509522https://doi.org/10.1007/s40273-017-0606-110.1007/s40273-017-0606-1Search in Google Scholar
Torrance, G. W., & Feeny, D. (1989). Utilities and Quality-Adjusted Life Years. International Journal of Technology Assessment in Health Care, 5(4), 559–575. https://doi.org/10.1017/s0266462300008461TorranceG. W.FeenyD.1989Utilities and Quality-Adjusted Life Years54559575https://doi.org/10.1017/s026646230000846110.1017/S0266462300008461Search in Google Scholar
Torrance, G. W., & Zipursky, A. (1984). Cost-Effectiveness of Antepartum Prevention of Rh Immunization. Clinics in Perinatology, 11(2), 267–281. https://doi.org/10.1016/s0095-5108(18)30920-5TorranceG. W.ZipurskyA.1984Cost-Effectiveness of Antepartum Prevention of Rh Immunization112267281https://doi.org/10.1016/s0095-5108(18)30920-510.1016/S0095-5108(18)30920-5Search in Google Scholar
Vallejo-Torres, L., García-Lorenzo, B., Castilla, I., Valcárcel-Nazco, C., García-Pérez, L., Linertová, R., et al. (2016). On the estimation of the cost-effectiveness threshold: Why, what, how?. Value in Health, 19(5), 558–566. https://doi.org/10.1016/j.jval.2016.02.020Vallejo-TorresL.García-LorenzoB.CastillaI.Valcárcel-NazcoC.García-PérezL.LinertováR.2016On the estimation of the cost-effectiveness threshold: Why, what, how?195558566https://doi.org/10.1016/j.jval.2016.02.02010.1016/j.jval.2016.02.020Search in Google Scholar
Williams, A. (1985). Economics of coronary artery bypass grafting. British Medical Journal (Clin Res Ed), 291(6491), 326–329. https://doi.org/10.1136/bmj.291.6491.326 291(6491), 326–329.WilliamsA.1985Economics of coronary artery bypass grafting2916491326329https://doi.org/10.1136/bmj.291.6491.326 291(6491), 326–329.10.1136/bmj.291.6491.326Search in Google Scholar
Woods, B., Revill, P., Sculpher, M., & Claxton, K. (2016). Country-level cost-effectiveness thresholds: Initial estimates and the need for further research. Value in Health, 19(8), 929–935. https://doi.org/10.1016/j.jval.2016.02.017WoodsB.RevillP.SculpherM.ClaxtonK.2016Country-level cost-effectiveness thresholds: Initial estimates and the need for further research198929935https://doi.org/10.1016/j.jval.2016.02.01710.1016/j.jval.2016.02.017Search in Google Scholar
Żylicz, T. (2014). Cena przyrody. Wydawnictwo Ekonomia i Środowisko.ŻyliczT.2014Wydawnictwo Ekonomia i ŚrodowiskoSearch in Google Scholar